Director sold ~$60K of Palantir
Scheduled in advanceTraded Jan 2, 2026 · Filed Jan 7, 2026
Sold under a plan set up in advance, so the timing wasn't a fresh decision
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$54,675
Shares × reported transaction price
60 days after results of Nov 3, 2025, 31 days before results of Feb 2, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $167.86 on Jan 2, 2026, 158% above its 52-week low and 19% below its high, little changed over the previous 30 trading days
52-week range $64.98 (Jan 13, 2025) to $207.18 (Nov 3, 2025), 72% of the way up, from 250 adjusted closes. 30 trading days earlier: $167.33 on Nov 18, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -1.8% | +0.1% | -1.9% |
| 30 days | -25.2% | +0.1% | -25.4% |
| 90 days | -17.4% | -4.4% | -13.0% |
| 180 days | -27.1% | +8.9% | -36.0% |
Past results only. Not a forecast.
Director sold ~$60K of Palantir
Scheduled in advanceDirector sold ~$106K of Palantir
Scheduled in advanceDirector sold ~$374K of Palantir
Scheduled in advance